These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


253 related items for PubMed ID: 21753735

  • 1. Inhibition of inflammation and fibrosis by a complement C5a receptor antagonist in DOCA-salt hypertensive rats.
    Iyer A, Woodruff TM, Wu MC, Stylianou C, Reid RC, Fairlie DP, Taylor SM, Brown L.
    J Cardiovasc Pharmacol; 2011 Nov; 58(5):479-86. PubMed ID: 21753735
    [Abstract] [Full Text] [Related]

  • 2. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
    O'Brien D, Chunduri P, Iyer A, Brown L.
    Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879
    [Abstract] [Full Text] [Related]

  • 3. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T, Miyauchi T, Sakai S, Takanashi M, Irukayama-Tomobe Y, Yamaguchi I.
    J Am Coll Cardiol; 2004 Apr 21; 43(8):1481-8. PubMed ID: 15093887
    [Abstract] [Full Text] [Related]

  • 4. Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA-salt hypertensive rats.
    Mirkovic S, Seymour AM, Fenning A, Strachan A, Margolin SB, Taylor SM, Brown L.
    Br J Pharmacol; 2002 Feb 21; 135(4):961-8. PubMed ID: 11861324
    [Abstract] [Full Text] [Related]

  • 5. Reversal of cardiac dysfunction by selective ET-A receptor antagonism.
    Allan A, Fenning A, Levick S, Hoey A, Brown L.
    Br J Pharmacol; 2005 Nov 21; 146(6):846-53. PubMed ID: 16151437
    [Abstract] [Full Text] [Related]

  • 6. Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
    Loch D, Levick S, Hoey A, Brown L.
    J Cardiovasc Pharmacol; 2006 Mar 21; 47(3):396-404. PubMed ID: 16633082
    [Abstract] [Full Text] [Related]

  • 7. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
    Brown L, Duce B, Miric G, Sernia C.
    J Am Soc Nephrol; 1999 Jan 21; 10 Suppl 11():S143-8. PubMed ID: 9892155
    [Abstract] [Full Text] [Related]

  • 8. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
    Brown L, Ooi SY, Lau K, Sernia C.
    Clin Exp Pharmacol Physiol; 2000 Apr 21; 27(4):263-9. PubMed ID: 10779123
    [Abstract] [Full Text] [Related]

  • 9. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
    Chan V, Hoey A, Brown L.
    Br J Pharmacol; 2006 Aug 21; 148(7):902-8. PubMed ID: 16783413
    [Abstract] [Full Text] [Related]

  • 10. Antagonist of C5aR prevents cardiac remodeling in angiotensin II-induced hypertension.
    Zhang C, Li Y, Wang C, Wu Y, Du J.
    Am J Hypertens; 2014 Jun 21; 27(6):857-64. PubMed ID: 24419904
    [Abstract] [Full Text] [Related]

  • 11. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
    Takeda K, Nakata T, Kuwabara T, Itoh H, Yamahara Y, Takesako T, Tanabe S, Sasaki S, Asayama J, Nakagawa M.
    Blood Press Suppl; 1992 Jun 21; 3():48-52. PubMed ID: 1343289
    [Abstract] [Full Text] [Related]

  • 12. Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM, Chen CC, Chang NC.
    Clin Sci (Lond); 2012 Oct 21; 123(7):445-57. PubMed ID: 22507072
    [Abstract] [Full Text] [Related]

  • 13. Attenuation of cardiovascular remodeling in DOCA-salt rats by the vasopeptidase inhibitor, omapatrilat.
    Loch D, Hoey A, Brown L.
    Clin Exp Hypertens; 2006 Jul 21; 28(5):475-88. PubMed ID: 16820344
    [Abstract] [Full Text] [Related]

  • 14. Increased calcium influx mediates increased cardiac stiffness in hyperthyroid rats.
    Levick S, Fenning A, Brown L.
    Cell Biochem Biophys; 2005 Jul 21; 43(1):53-60. PubMed ID: 16043883
    [Abstract] [Full Text] [Related]

  • 15. Left ventricular compliance in the DOCA-salt model of hypertension in the rat. Effects of propranolol.
    Cheav SL, Delcayre C, Besnard JC, Paolaggi F, Mouas C, Swynghedauw B.
    Arch Int Pharmacodyn Ther; 1991 Jul 21; 314():5-24. PubMed ID: 1840461
    [Abstract] [Full Text] [Related]

  • 16. Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy.
    Ebrahim Z, Yellon DM, Baxter GF.
    Pharmacol Res; 2007 Jan 21; 55(1):42-8. PubMed ID: 17079163
    [Abstract] [Full Text] [Related]

  • 17. Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation.
    Vergunst CE, Gerlag DM, Dinant H, Schulz L, Vinkenoog M, Smeets TJ, Sanders ME, Reedquist KA, Tak PP.
    Rheumatology (Oxford); 2007 Dec 21; 46(12):1773-8. PubMed ID: 17965442
    [Abstract] [Full Text] [Related]

  • 18. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.
    Karam H, Heudes D, Hess P, Gonzales MF, Löffler BM, Clozel M, Clozel JP.
    Cardiovasc Res; 1996 Feb 21; 31(2):287-95. PubMed ID: 8730406
    [Abstract] [Full Text] [Related]

  • 19. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats.
    Robin S, Maupoil V, Laurant P, Jacqueson A, Berthelot A.
    Br J Nutr; 2004 Jun 21; 91(6):857-65. PubMed ID: 15182389
    [Abstract] [Full Text] [Related]

  • 20. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
    Rothermund L, Vetter R, Dieterich M, Kossmehl P, Gögebakan O, Yagil C, Yagil Y, Kreutz R.
    Circulation; 2002 Oct 29; 106(18):2305-8. PubMed ID: 12403658
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.